drugset / Trial / NCT00409851

One Year Study to Evaluate the Safety of the Combination of Valsartan and Amlodipine in Patients With Hypertension

NCT00409851

Phase 3 Completed 1293 enrolled Novartis
RandomizedParallel-groupOpen-labelTreatment

Summary

A ONE YEAR SAFETY STUDY FOR PATIENTS WHO COMPLETE STUDY VAA489A2201.

Timeline

Start
2003-04
Primary completion
2005-03
Completion
2005-03

Drugs

EvaluationDrugModalityDoseRoute
Subject Amlodipine Other / unclassified
Subject Valsartan Small molecule

Indications